Verdict86/ 100
Grade B · #12Sprout Health
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
Visit Sprout HealthHead-to-head verdict
Sprout Health vs Vaylen
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.
vs
Verdict88/ 100
Grade B+ · #5Vaylen
The widest formulary on the board — both molecules, brand-name and oral routes — nationwide and LegitScript-verified.
Visit VaylenThe verdict
Winner: Vaylen
Vaylen takes it with a higher Verdict Score — 88/100 to 86/100 (grade B+ vs B). Anyone who wants every option on one account: compounded, brand-name or oral, without leaving to shop around. Sprout Health still earns its place — patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
82Real-world results86
82
Real-world results86
90Price honesty87
90
Price honesty87
82Prescriber access90
82
Prescriber access90
86Formulary choice91
86
Formulary choice91
80Cancellation fairness86
80
Cancellation fairness86
78Member support86
78
Member support86
Price, coverage & features
| Metric | Sprout Health | Vaylen |
|---|---|---|
| Verdict Score | 86/100 | 88/100 |
| Grade | B | B+ |
| Semaglutide | $149/mo | $179/mo |
| Tirzepatide | $199/mo | $239/mo |
| Coverage | Not disclosed | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | No | Yes |
Sprout Health
What we like
- LegitScript-certified with a listed address and contact line
- Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
- Low-friction intake — no labs and often no telehealth visit required
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved
- No oral or sublingual route — injectable only
- Thin transparency — no named medical director, and state availability is quiz-gated
- "No labs, no visit" convenience also means lighter clinical oversight
Vaylen
What we like
- Full formulary: both molecules plus brand-name and oral routes
- LegitScript-certified and available in all 50 states
- Fair mid-market pricing for the breadth on offer
The caveats
- Not the cheapest per molecule
- Younger brand without a long outcomes record
Also worth a look
Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
Visit Sprout Health Read the full Sprout Health review →Our pick — visit
Anyone who wants every option on one account: compounded, brand-name or oral, without leaving to shop around.
Visit Vaylen Read the full Vaylen review →Keep comparing
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.